Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?
Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?
复制标题
DOI:
10.1007/s40520-021-01987-9
复制
发表时间:
2021-11
影响因子:
4
通讯作者:
Gravenstein S
中科院分区:
文献类型:
--
作者:
Oyebanji OA;Wilson B;Keresztesy D;Carias L;Wilk D;Payne M;Aung H;Denis KS;Lam EC;Rowley CF;Berry SD;Cameron CM;Cameron MJ;Schmader KE;Balazs AB;King CL;Canaday DH;Gravenstein S
The BNT162b2 SARS-CoV-2 mRNA vaccination has mitigated the burden of COVID-19 among residents of long-term care facilities considerably, despite being excluded from the vaccine trials. Data on reactogenicity (vaccine side effects) in this population are limited. To assess reactogenicity among nursing home (NH) residents. To provide a plausible proxy for predicting vaccine response among this population. We enrolled and sampled NH residents and community-dwelling healthcare workers who received the BNT162b2 mRNA vaccine, to assess local or systemic reactogenicity and antibody levels (immunogenicity). NH residents reported reactions at a much lower frequency and lesser severity than the community-dwelling healthcare workers. These reactions were mild and transient with all subjects experiencing more local than systemic reactions. Based on our reactogenicity and immunogenicity data, we developed a linear regression model predicting log-transformed anti-spike, anti-receptor-binding domain (RBD), and neutralizing titers, with a dichotomous variable indicating the presence or absence of reported reactions which revealed a statistically significant effect, with estimated shifts in log-transformed titers ranging from 0.32 to 0.37 (all p < 0.01) indicating greater immunogenicity in subjects with one or more reported reactions of varying severity. With a significantly lower incidence of post-vaccination reactions among NH residents as reported in this study, the BNT162b2 mRNA vaccine appears to be well-tolerated among this vulnerable population. If validated in larger populations, absence of reactogenicity could help guide clinicians in prioritizing vaccine boosters. Reactogenicity is significantly mild among nursing home residents and overall, subjects who reported post-vaccination reactions developed higher antibody titers. The online version contains supplementary material available at 10.1007/s40520-021-01987-9.
登录
查看更多内容
DOI:
10.1056/nejmoa2034577
发表时间:
2020-12-31
期刊:
The New England journal of medicine
影响因子:
--
作者:
Polack FP;Thomas SJ;Kitchin N;Absalon J;Gurtman A;Lockhart S;Perez JL;Pérez Marc G;Moreira ED;Zerbini C;Bailey R;Swanson KA;Roychoudhury S;Koury K;Li P;Kalina WV;Cooper D;Frenck RW Jr;Hammitt LL;Türeci Ö;Nell H;Schaefer A;Ünal S;Tresnan DB;Mather S;Dormitzer PR;Şahin U;Jansen KU;Gruber WC;C4591001 Clinical Trial Group
通讯作者:
C4591001 Clinical Trial Group
影响因子:
82.9
作者:
Ebinger JE;Fert-Bober J;Printsev I;Wu M;Sun N;Prostko JC;Frias EC;Stewart JL;Van Eyk JE;Braun JG;Cheng S;Sobhani K
通讯作者:
Sobhani K
DOI:
10.3390/life11030249
发表时间:
2021-03-17
期刊:
Life (Basel, Switzerland)
影响因子:
--
作者:
Mathioudakis AG;Ghrew M;Ustianowski A;Ahmad S;Borrow R;Papavasileiou LP;Petrakis D;Bakerly ND
通讯作者:
Bakerly ND
影响因子:
2.6
作者:
Joelson, S;Joelson, IB;Wallander, MA
通讯作者:
Wallander, MA
影响因子:
11.8
作者:
Mueller, Lisa;Andree, Marcel;Schaal, Heiner
通讯作者:
Schaal, Heiner